BMI declines seen seven years before cognitive impairment diagnosis

BMI declines seen seven years before cognitive impairment diagnosis

Significantly lower body mass index (BMI) occurs beginning approximately seven years before a diagnosis of mild cognitive impairment (MCI), according to a study published online Oct. 26 in JAMA Psychiatry.

Jie Guo, M.P.H., from the Karolinska Institutet in Stockholm, and colleagues assessed the long-term BMI trajectories preceding incident MCI and dementia. The analysis included 1,390 participants (mean age, 78.4 years; 76.5 percent female).

The researchers found that compared with participants who remained cognitively intact, BMI tended to decline earlier and faster in those with incident MCI. People with incident MCI had an associated significantly lower BMI from seven years before than those who were cognitively intact. However, the slopes of BMI decline did not differ significantly between those with incident MCI who did and did not develop dementia. In a subset of 358 people with autopsy data, BMI was associated with a faster declination among participants with a high burden of global Alzheimer disease or vascular pathology.

"Our findings suggest that the high levels of Alzheimer disease pathology or cerebral vascular disease pathology may be associated with the BMI decline preceding MCI," the authors write. "Future imaging studies (e.g., using ) are warranted to clarify the temporal association between BMI change and brain pathologies."

More information: Jie Guo et al, Body Mass Index Trajectories Preceding Incident Mild Cognitive Impairment and Dementia, JAMA Psychiatry (2022). DOI: 10.1001/jamapsychiatry.2022.3446

Journal information: JAMA Psychiatry

Copyright © 2022 HealthDay. All rights reserved.

Citation: BMI declines seen seven years before cognitive impairment diagnosis (2022, November 3) retrieved 16 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Novel PET imaging agent detects earliest signs of Alzheimer's disease


Feedback to editors